<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(5)</volume><submitter>Luta X</submitter><pubmed_abstract>Head and neck cancer (HNC) patients experience distressing symptoms that can significantly impact their health-related quality of life (HRQoL). We analyzed the implementation of a nurse-led consultation (NLC) and explored potential associations with symptom burden in HNC patients. We retrospectively analyzed routinely collected data to describe the implementation of the nurse-led interventions and the evolution of the M.D. Anderson Symptom Inventory scores as patient-reported outcome measures (PROMs). Patients who received routine care (n = 72) were compared with patients in the NLC group (n = 62) at a radiation oncology unit between 2017 and 2019. PROMs were measured at T0 (between simulation and the first week of radiotherapy), T1 (week 3-4), and T2 (week 5-6). Screening for nutrition, smoking, oral cavity status, and capacity for swallowing/chewing, but not for pain, was applied in &amp;gt;80% of patients in the NLC group from T0 to T1. Education (16%) and care coordination (7%) were implemented to a lesser extent. Symptom burden increased over time with no significant differences between groups. The nurse-led consultation was not associated with symptom burden over time. A larger implementation study including a detailed process evaluation, larger sample size, and a focus on long-term effects is needed.</pubmed_abstract><journal>Cancers</journal><pagination>1227</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8909718</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Nurse-Led Consultation and Symptom Burden in Patients with Head and Neck Cancer: A Comparative Analysis of Routine Clinical Data.</pubmed_title><pmcid>PMC8909718</pmcid><pubmed_authors>Fucina N</pubmed_authors><pubmed_authors>Colomer-Lahiguera S</pubmed_authors><pubmed_authors>Martins Cardoso RJ</pubmed_authors><pubmed_authors>Bourhis J</pubmed_authors><pubmed_authors>Ninane F</pubmed_authors><pubmed_authors>Debarge P</pubmed_authors><pubmed_authors>Savoie M</pubmed_authors><pubmed_authors>Wicht J</pubmed_authors><pubmed_authors>Luta X</pubmed_authors><pubmed_authors>Schuler C</pubmed_authors><pubmed_authors>Eicher M</pubmed_authors><pubmed_authors>Hof F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Nurse-Led Consultation and Symptom Burden in Patients with Head and Neck Cancer: A Comparative Analysis of Routine Clinical Data.</name><description>Head and neck cancer (HNC) patients experience distressing symptoms that can significantly impact their health-related quality of life (HRQoL). We analyzed the implementation of a nurse-led consultation (NLC) and explored potential associations with symptom burden in HNC patients. We retrospectively analyzed routinely collected data to describe the implementation of the nurse-led interventions and the evolution of the M.D. Anderson Symptom Inventory scores as patient-reported outcome measures (PROMs). Patients who received routine care (n = 72) were compared with patients in the NLC group (n = 62) at a radiation oncology unit between 2017 and 2019. PROMs were measured at T0 (between simulation and the first week of radiotherapy), T1 (week 3-4), and T2 (week 5-6). Screening for nutrition, smoking, oral cavity status, and capacity for swallowing/chewing, but not for pain, was applied in &amp;gt;80% of patients in the NLC group from T0 to T1. Education (16%) and care coordination (7%) were implemented to a lesser extent. Symptom burden increased over time with no significant differences between groups. The nurse-led consultation was not associated with symptom burden over time. A larger implementation study including a detailed process evaluation, larger sample size, and a focus on long-term effects is needed.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2025-04-21T23:16:29.593Z</modification><creation>2025-04-05T19:05:34.573Z</creation></dates><accession>S-EPMC8909718</accession><cross_references><pubmed>35267536</pubmed><doi>10.3390/cancers14051227</doi></cross_references></HashMap>